Human Leukocyte Antigen (HLA) Antibody Screening Global Market Report 2026

Description

Human leukocyte antigen (HLA) antibody screening is a laboratory procedure used to detect antibodies targeting human leukocyte antigen (HLA) molecules in a person's blood. These antibodies can develop from previous exposure to foreign HLA proteins through events such as blood transfusions, pregnancy, or organ transplants. HLA antibody screening helps evaluate immunological risk by identifying sensitization that could cause complications in transplant compatibility or immune-mediated reactions.

The primary technology types of human leukocyte antigen (HLA) antibody screening include enzyme-linked immunosorbent assay (ELISA), flow cytometry, luminex, and others. ELISA is a laboratory technique that detects and quantifies specific proteins, antigens, or antibodies in a sample using enzyme-linked antibodies that produce a measurable color change. Product types include reagents and kits, instruments, and software, targeting human leukocyte antigen class I antibodies, human leukocyte antigen class II antibodies, and non-human leukocyte antigen antibodies. Applications include pre-transplant screening, post-transplant monitoring, transfusion medicine, and research, serving hospitals and transplant centers, diagnostic laboratories, research institutes, and other end-users.

Tariffs on imported diagnostic reagents, bead-based assay kits, and specialized flow cytometry instruments are impacting the HLA antibody screening market by increasing procurement costs for hospitals and transplant laboratories. Segments such as reagents and kits and luminex-based technologies are particularly affected, especially in regions reliant on imported immunoassay systems including Asia-Pacific and Latin America. Higher tariffs may constrain laboratory budgets and delay equipment upgrades; however, they are also encouraging domestic manufacturing of assay kits and localized production of diagnostic instruments, fostering supply chain diversification and long-term regional self-sufficiency.

The human leukocyte antigen (HLA) antibody screening market research report is one of a series of new reports from The Business Research Company that provides human leukocyte antigen (HLA) antibody screening market statistics, including human leukocyte antigen (HLA) antibody screening industry global market size, regional shares, competitors with a human leukocyte antigen (HLA) antibody screening market share, detailed human leukocyte antigen (HLA) antibody screening market segments, market trends and opportunities, and any further data you may need to thrive in the human leukocyte antigen (HLA) antibody screening industry. This human leukocyte antigen (HLA) antibody screening market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The human leukocyte antigen (HLA) antibody screening market size has grown strongly in recent years. It will grow from $0.98 billion in 2025 to $1.06 billion in 2026 at a compound annual growth rate (CAGR) of 8.4%. The growth in the historic period can be attributed to rising number of organ transplant procedures, increasing incidence of end-stage organ failure, growing awareness of transplant rejection risks, expansion of transfusion medicine practices, technological advancements in immunoassay platforms.

The human leukocyte antigen (HLA) antibody screening market size is expected to see strong growth in the next few years. It will grow to $1.47 billion in 2030 at a compound annual growth rate (CAGR) of 8.6%. The growth in the forecast period can be attributed to increasing demand for precision transplant matching, growing adoption of multiplex bead-based assays, rising investments in transplant immunology research, expansion of transplant programs in emerging markets, technological innovation in automated hla antibody screening systems. Major trends in the forecast period include increasing adoption of single antigen bead assays for enhanced sensitivity, rising demand for comprehensive pre-transplant immunological risk assessment, growing use of high-throughput flow cytometry in hla screening, expansion of post-transplant antibody monitoring protocols, increasing standardization of hla antibody detection methods.

The increasing rates of organ transplantation are anticipated to drive the expansion of the HLA antibody screening market in the coming years. Organ transplantation rates indicate the number of organ transplant procedures carried out within a particular population over a defined period, typically measured annually or per million individuals. This growth in transplantation procedures is mainly due to the rising prevalence of chronic and end-stage diseases; as more patients progress to organ failure, the demand for organ replacement therapies correspondingly rises. HLA antibody screening enhances the success of organ transplants by ensuring improved donor-recipient compatibility prior to surgery, thereby reducing the risk of immune-mediated rejection, minimizing graft loss and complications, enhancing long-term transplant outcomes, and allowing more efficient use of available donor organs. For example, in January 2025, the Health Resources and Services Administration, a US Department of Health and Human Services agency, reported that lung transplants saw the largest proportional increase between 2023 and 2024, rising from 3,026 to 3,340 procedures, representing a 10.4% growth. Hence, the rising organ transplantation rates are fueling the growth of the HLA antibody screening market.

Leading companies operating in the HLA antibody screening market are focusing on developing next-generation HLA research tools to improve immune checkpoint research, antibody validation, and assay development accuracy. Next-generation HLA research tools comprise innovative recombinant reagents, multiplexed analytical platforms, and high-resolution molecular technologies that allow precise profiling of HLA molecules and their antibody interactions. For example, in November 2025, HLA Protein Technologies, a US-based biotechnology company, launched its sHLA-G Monomer and Tetramer Portfolio, a next-generation HLA research tool that supports high-fidelity checkpoint biology studies, target validation, and assay development. The portfolio provides structurally validated recombinant HLA-G reagents optimized for immune receptor interaction studies, facilitating enhanced characterization of HLA-associated antibodies and advancing applications in transplant immunology, oncology, and immune tolerance research.

In June 2023, Innobiochips, a France-based biotechnology company, entered into a technology licensing agreement with BAG Diagnostics to advance transplantation diagnostics by providing broader access to high-precision HLA antibody screening technologies. The collaboration is designed to reinforce Innobiochips' presence in the transplantation diagnostics sector through the licensing and commercialization of BAG Diagnostics' HLA antibody screening solutions, improving transplant compatibility testing. BAG Diagnostics is a Germany-based diagnostics company specializing in HLA typing and antibody screening assays for transplantation medicine.

Major companies operating in the human leukocyte antigen (HLA) antibody screening market are Hoffmann-La Roche AG, Thermo Fisher Scientific Inc., Abbott Laboratories, Becton Dickinson Company, Laboratory Corporation of America Holdings, Quest Diagnostics Incorporated, Grifols S A, Beckman Coulter Inc., Bio Rad Laboratories Inc., QIAGEN N V, Takara Bio Inc., Fujirebio Inc., CareDx Inc., Histogenetics LLC, Creative Biolabs Inc., Biofortuna Ltd., Stanford Blood Center, GenDx B V, Omixon Biocomputing Ltd., BAG Diagnostics GmbH, Scisco Genetics Inc., TBG Diagnostics Ltd., American Red Cross.

North America was the largest region in the human leukocyte antigen (HLA) antibody screening market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the human leukocyte antigen (HLA) antibody screening market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the human leukocyte antigen (HLA) antibody screening market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The human leukocyte antigen (HLA) antibody screening market consists of revenues earned by entities by providing services such as panel reactive antibody (PRA) testing, donor-specific antibody (DSA) identification, crossmatch testing, and antibody specificity and strength characterization. The market value includes the value of related goods sold by the service provider or included within the service offering. The human leukocyte antigen (HLA) antibody screening market also includes sales of automated ELISA processors, microplate washers, and fluorescence detection systems. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Human Leukocyte Antigen (HLA) Antibody Screening Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses human leukocyte antigen (hla) antibody screening market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on end user analysis.
Benchmark performance against key competitors based on market share, innovation, and brand strength.
Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for human leukocyte antigen (hla) antibody screening ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The human leukocyte antigen (hla) antibody screening market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

Markets Covered:1) By Technology: Enzyme-Linked Immunosorbent Assay (ELISA); Flow Cytometry; Luminex; Other Technologies
2) By Product Type: Reagents And Kits; Instruments; Software
3) By Target Class: Human Leukocyte Antigen Class I Antibodies; Human Leukocyte Antigen Class II Antibodies; Non- Human Leukocyte Antigen Antibodies
4) By Application: Pre-Transplant Screening; Post-Transplant Monitoring; Transfusion Medicine; Research Applications
5) By End-User: Hospitals And Transplant Centers; Diagnostic Laboratories; Research Institutes; Other End-Users
Subsegments:
1) By Enzyme Linked Immunosorbent Assay: Direct Enzyme Linked Immunosorbent Assay; Indirect Enzyme Linked Immunosorbent Assay; Sandwich Enzyme Linked Immunosorbent Assay; Competitive Enzyme Linked Immunosorbent Assay
2) By Flow Cytometry: Conventional Flow Cytometry; Bead Based Flow Cytometry; Imaging Flow Cytometry; High Throughput Flow Cytometry
3) By Luminex: Single Antigen Luminex Assay; Multi Antigen Luminex Assay; Bead Based Multiplex Luminex Assay; Custom Luminex Panels
4) By Other Technologies: Western Blotting; Radioimmunoassay; Complement Dependent Cytotoxicity Assay; Microarray Based Assay
Companies Mentioned: Hoffmann-La Roche AG; Thermo Fisher Scientific Inc.; Abbott Laboratories; Becton Dickinson Company; Laboratory Corporation of America Holdings; Quest Diagnostics Incorporated; Grifols S A; Beckman Coulter Inc.; Bio Rad Laboratories Inc.; QIAGEN N V; Takara Bio Inc.; Fujirebio Inc.; CareDx Inc.; Histogenetics LLC; Creative Biolabs Inc.; Biofortuna Ltd.; Stanford Blood Center; GenDx B V; Omixon Biocomputing Ltd.; BAG Diagnostics GmbH; Scisco Genetics Inc.; TBG Diagnostics Ltd.; American Red Cross.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report
+ Excel Dashboard
Added Benefits
Bi-Annual Data Update
Customisation
Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Product Code: HS4MHLAH01_G26Q2

1. Executive Summary

1.1. Key Market Insights (2020-2035)
1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
1.3. Major Factors Driving the Market
1.4. Top Three Trends Shaping the Market

2. Human Leukocyte Antigen (HLA) Antibody Screening Market Characteristics

2.1. Market Definition & Scope
2.2. Market Segmentations
2.3. Overview of Key Products and Services
2.4. Global Human Leukocyte Antigen (HLA) Antibody Screening Market Attractiveness Scoring And Analysis
- 2.4.1. Overview of Market Attractiveness Framework
- 2.4.2. Quantitative Scoring Methodology
- 2.4.3. Factor-Wise Evaluation
Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation

2.4.4. Market Attractiveness Scoring and Interpretation
2.4.5. Strategic Implications and Recommendations

3. Human Leukocyte Antigen (HLA) Antibody Screening Market Supply Chain Analysis

3.1. Overview of the Supply Chain and Ecosystem
3.2. List Of Key Raw Materials, Resources & Suppliers
3.3. List Of Major Distributors and Channel Partners
3.4. List Of Major End Users

4. Global Human Leukocyte Antigen (HLA) Antibody Screening Market Trends And Strategies

4.1. Key Technologies & Future Trends
- 4.1.1 Biotechnology, Genomics & Precision Medicine
- 4.1.2 Artificial Intelligence & Autonomous Intelligence
- 4.1.3 Digitalization, Cloud, Big Data & Cybersecurity
- 4.1.4 Industry 4.0 & Intelligent Manufacturing
- 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
4.2. Major Trends
- 4.2.1 Increasing Adoption of Single Antigen Bead Assays for Enhanced Sensitivity
- 4.2.2 Rising Demand for Comprehensive Pre-Transplant Immunological Risk Assessment
- 4.2.3 Growing Use of High-Throughput Flow Cytometry in HLA Screening
- 4.2.4 Expansion of Post-Transplant Antibody Monitoring Protocols
- 4.2.5 Increasing Standardization of HLA Antibody Detection Methods

5. Human Leukocyte Antigen (HLA) Antibody Screening Market Analysis Of End Use Industries

5.1 Hospitals And Transplant Centers
5.2 Diagnostic Laboratories
5.3 Research Institutes
5.4 Blood Banks
5.5 Immunology Reference Laboratories

6. Human Leukocyte Antigen (HLA) Antibody Screening Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Human Leukocyte Antigen (HLA) Antibody Screening Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

7.1. Global Human Leukocyte Antigen (HLA) Antibody Screening PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
7.2. Global Human Leukocyte Antigen (HLA) Antibody Screening Market Size, Comparisons And Growth Rate Analysis
7.3. Global Human Leukocyte Antigen (HLA) Antibody Screening Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
7.4. Global Human Leukocyte Antigen (HLA) Antibody Screening Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Human Leukocyte Antigen (HLA) Antibody Screening Total Addressable Market (TAM) Analysis for the Market

8.1. Definition and Scope of Total Addressable Market (TAM)
8.2. Methodology and Assumptions
8.3. Global Total Addressable Market (TAM) Estimation
8.4. TAM vs. Current Market Size Analysis
8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Human Leukocyte Antigen (HLA) Antibody Screening Market Segmentation

9.1. Global Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Enzyme-Linked Immunosorbent Assay (ELISA), Flow Cytometry, Luminex, Other Technologies
9.2. Global Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Product Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Reagents And Kits, Instruments, Software
9.3. Global Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Human Leukocyte Antigen Class I Antibodies, Human Leukocyte Antigen Class II Antibodies, Non- Human Leukocyte Antigen Antibodies
9.4. Global Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Application, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Pre-Transplant Screening, Post-Transplant Monitoring, Transfusion Medicine, Research Applications
9.5. Global Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By End-User, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Hospitals And Transplant Centers, Diagnostic Laboratories, Research Institutes, Other End-Users
9.6. Global Human Leukocyte Antigen (HLA) Antibody Screening Market, Sub-Segmentation Of Enzyme Linked Immunosorbent Assay, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Direct Enzyme Linked Immunosorbent Assay, Indirect Enzyme Linked Immunosorbent Assay, Sandwich Enzyme Linked Immunosorbent Assay, Competitive Enzyme Linked Immunosorbent Assay
9.7. Global Human Leukocyte Antigen (HLA) Antibody Screening Market, Sub-Segmentation Of Flow Cytometry, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Conventional Flow Cytometry, Bead Based Flow Cytometry, Imaging Flow Cytometry, High Throughput Flow Cytometry
9.8. Global Human Leukocyte Antigen (HLA) Antibody Screening Market, Sub-Segmentation Of Luminex, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Single Antigen Luminex Assay, Multi Antigen Luminex Assay, Bead Based Multiplex Luminex Assay, Custom Luminex Panels
9.9. Global Human Leukocyte Antigen (HLA) Antibody Screening Market, Sub-Segmentation Of Other Technologies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
Western Blotting, Radioimmunoassay, Complement Dependent Cytotoxicity Assay, Microarray Based Assay

10. Human Leukocyte Antigen (HLA) Antibody Screening Market Regional And Country Analysis

10.1. Global Human Leukocyte Antigen (HLA) Antibody Screening Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
10.2. Global Human Leukocyte Antigen (HLA) Antibody Screening Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Human Leukocyte Antigen (HLA) Antibody Screening Market

11.1. Asia-Pacific Human Leukocyte Antigen (HLA) Antibody Screening Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
11.2. Asia-Pacific Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Human Leukocyte Antigen (HLA) Antibody Screening Market

12.1. China Human Leukocyte Antigen (HLA) Antibody Screening Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
12.2. China Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Human Leukocyte Antigen (HLA) Antibody Screening Market

13.1. India Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Human Leukocyte Antigen (HLA) Antibody Screening Market

14.1. Japan Human Leukocyte Antigen (HLA) Antibody Screening Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
14.2. Japan Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Human Leukocyte Antigen (HLA) Antibody Screening Market

15.1. Australia Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Human Leukocyte Antigen (HLA) Antibody Screening Market

16.1. Indonesia Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Human Leukocyte Antigen (HLA) Antibody Screening Market

17.1. South Korea Human Leukocyte Antigen (HLA) Antibody Screening Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
17.2. South Korea Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Human Leukocyte Antigen (HLA) Antibody Screening Market

18.1. Taiwan Human Leukocyte Antigen (HLA) Antibody Screening Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
18.2. Taiwan Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Human Leukocyte Antigen (HLA) Antibody Screening Market

19.1. South East Asia Human Leukocyte Antigen (HLA) Antibody Screening Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
19.2. South East Asia Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Human Leukocyte Antigen (HLA) Antibody Screening Market

20.1. Western Europe Human Leukocyte Antigen (HLA) Antibody Screening Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
20.2. Western Europe Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Human Leukocyte Antigen (HLA) Antibody Screening Market

21.1. UK Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Human Leukocyte Antigen (HLA) Antibody Screening Market

22.1. Germany Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Human Leukocyte Antigen (HLA) Antibody Screening Market

23.1. France Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Human Leukocyte Antigen (HLA) Antibody Screening Market

24.1. Italy Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Human Leukocyte Antigen (HLA) Antibody Screening Market

25.1. Spain Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Human Leukocyte Antigen (HLA) Antibody Screening Market

26.1. Eastern Europe Human Leukocyte Antigen (HLA) Antibody Screening Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
26.2. Eastern Europe Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Human Leukocyte Antigen (HLA) Antibody Screening Market

27.1. Russia Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Human Leukocyte Antigen (HLA) Antibody Screening Market

28.1. North America Human Leukocyte Antigen (HLA) Antibody Screening Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
28.2. North America Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Human Leukocyte Antigen (HLA) Antibody Screening Market

29.1. USA Human Leukocyte Antigen (HLA) Antibody Screening Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
29.2. USA Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Human Leukocyte Antigen (HLA) Antibody Screening Market

30.1. Canada Human Leukocyte Antigen (HLA) Antibody Screening Market Overview
Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
30.2. Canada Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Human Leukocyte Antigen (HLA) Antibody Screening Market

31.1. South America Human Leukocyte Antigen (HLA) Antibody Screening Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
31.2. South America Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Human Leukocyte Antigen (HLA) Antibody Screening Market

32.1. Brazil Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Human Leukocyte Antigen (HLA) Antibody Screening Market

33.1. Middle East Human Leukocyte Antigen (HLA) Antibody Screening Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
33.2. Middle East Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Human Leukocyte Antigen (HLA) Antibody Screening Market

34.1. Africa Human Leukocyte Antigen (HLA) Antibody Screening Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
34.2. Africa Human Leukocyte Antigen (HLA) Antibody Screening Market, Segmentation By Technology, Segmentation By Product Type, Segmentation By Target Class, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Human Leukocyte Antigen (HLA) Antibody Screening Market Regulatory and Investment Landscape

36. Human Leukocyte Antigen (HLA) Antibody Screening Market Competitive Landscape And Company Profiles

36.1. Human Leukocyte Antigen (HLA) Antibody Screening Market Competitive Landscape And Market Share 2024
- 36.1.1. Top 10 Companies (Ranked by revenue/share)
36.2. Human Leukocyte Antigen (HLA) Antibody Screening Market - Company Scoring Matrix
- 36.2.1. Market Revenues
- 36.2.2. Product Innovation Score
- 36.2.3. Brand Recognition
36.3. Human Leukocyte Antigen (HLA) Antibody Screening Market Company Profiles
- 36.3.1. Hoffmann-La Roche AG Overview, Products and Services, Strategy and Financial Analysis
- 36.3.2. Thermo Fisher Scientific Inc. Overview, Products and Services, Strategy and Financial Analysis
- 36.3.3. Abbott Laboratories Overview, Products and Services, Strategy and Financial Analysis
- 36.3.4. Becton Dickinson Company Overview, Products and Services, Strategy and Financial Analysis
- 36.3.5. Laboratory Corporation of America Holdings Overview, Products and Services, Strategy and Financial Analysis

37. Human Leukocyte Antigen (HLA) Antibody Screening Market Other Major And Innovative Companies

Quest Diagnostics Incorporated, Grifols S A, Beckman Coulter Inc., Bio Rad Laboratories Inc., QIAGEN N V, Takara Bio Inc., Fujirebio Inc., CareDx Inc., Histogenetics LLC, Creative Biolabs Inc., Biofortuna Ltd., Stanford Blood Center, GenDx B V, Omixon Biocomputing Ltd., BAG Diagnostics GmbH

38. Global Human Leukocyte Antigen (HLA) Antibody Screening Market Competitive Benchmarking And Dashboard

39. Upcoming Startups in the Market

40. Key Mergers And Acquisitions In The Human Leukocyte Antigen (HLA) Antibody Screening Market

41. Human Leukocyte Antigen (HLA) Antibody Screening Market High Potential Countries, Segments and Strategies

41.1 Human Leukocyte Antigen (HLA) Antibody Screening Market In 2030 - Countries Offering Most New Opportunities
41.2 Human Leukocyte Antigen (HLA) Antibody Screening Market In 2030 - Segments Offering Most New Opportunities
41.3 Human Leukocyte Antigen (HLA) Antibody Screening Market In 2030 - Growth Strategies
- 41.3.1 Market Trend Based Strategies
- 41.3.2 Competitor Strategies

42. Appendix

42.1. Abbreviations
42.2. Currencies
42.3. Historic And Forecast Inflation Rates
42.4. Research Inquiries
42.5. The Business Research Company
42.6. Copyright And Disclaimer